Show simple item record

Editorial: Nucleic Acids Research and Nucleic Acid Therapeutics

dc.contributor.authorStoddard, Barry L.
dc.contributor.authorKhvorova, Anastasia
dc.contributor.authorCorey, David R.
dc.contributor.authorDynan, William S.
dc.contributor.authorFox, Keith R.
dc.date2022-08-11T08:10:52.000
dc.date.accessioned2022-08-23T17:22:47Z
dc.date.available2022-08-23T17:22:47Z
dc.date.issued2018-02-28
dc.date.submitted2018-04-26
dc.identifier.citation<p>Nucleic Acids Res. 2018 Feb 28;46(4):1563-1564. doi: 10.1093/nar/gky059. <a href="https://doi.org/10.1093/nar/gky059">Link to article on publisher's site</a></p>
dc.identifier.issn0305-1048 (Linking)
dc.identifier.doi10.1093/nar/gky059
dc.identifier.pmid29506274
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48819
dc.description.abstractNucleic Acids Research has recently commissioned the publication of a series of Survey and Summary articles that encapsulate the current ‘state of the art’ surrounding the creation, function, behavior and optimization of nucleic acid molecules that may be adopted for clinical applications.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29506274&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact moc.puo@snoissimrep.slanruoj
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectBiochemistry, Biophysics, and Structural Biology
dc.subjectCell and Developmental Biology
dc.subjectGenetics and Genomics
dc.subjectNucleic Acids, Nucleotides, and Nucleosides
dc.subjectTherapeutics
dc.titleEditorial: Nucleic Acids Research and Nucleic Acid Therapeutics
dc.typeEditorial
dc.source.journaltitleNucleic acids research
dc.source.volume46
dc.source.issue4
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1002&amp;context=rti_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/rti_pubs/3
dc.identifier.contextkey12026034
refterms.dateFOA2022-08-23T17:22:47Z
html.description.abstract<p><em>Nucleic Acids Research</em> has recently commissioned the publication of a series of Survey and Summary articles that encapsulate the current ‘state of the art’ surrounding the creation, function, behavior and optimization of nucleic acid molecules that may be adopted for clinical applications.</p>
dc.identifier.submissionpathrti_pubs/3
dc.contributor.departmentRNA Therapeutics Institute
dc.source.pages1563-1564


Files in this item

Thumbnail
Name:
gky059.pdf
Size:
42.94Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

Copyright © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact moc.puo@snoissimrep.slanruoj
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact moc.puo@snoissimrep.slanruoj